Papers

3

Total Citations

39

H-Index

3

About

Masanobu Saruta is a pioneering urologic surgeon whose research centers on optimizing robotic-assisted surgical outcomes for prostate and bladder cancers. His work has fundamentally advanced our understanding of how surgical technique and perioperative care affect patient recovery and quality of life. Dr. Saruta’s landmark study on pentafecta outcomes—a composite measure of continence, potency, cancer control, negative surgical margins, and complication avoidance—demonstrated that nerve-sparing robot-assisted radical prostatectomy (RARP) significantly improves these critical endpoints, with 24 citations underscoring its clinical relevance. He has also been at the forefront of enhanced recovery after surgery (ERAS) protocols, showing that such pathways reduce postoperative ileus in frail patients undergoing robot-assisted radical cystectomy with intracorporeal urinary diversion. Notably, Dr. Saruta reported the first Japanese single-center experience with the Hugo™ RAS system, a novel robotic platform, achieving safe and effective perioperative outcomes for RARP. His contributions are shaping the next generation of minimally invasive urologic oncology, with a clear focus on patient-centered outcomes and surgical innovation.

Research Focus

Key Achievements

3
H-Index
3
Papers
39
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study
24 citations · 2023
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Fujita Health University Hospital, Fujita Health University

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago